Proof-of-concept experiments showed that these retroviral vectors could be used to express the multidrug resistance protein 1 (mdr-1) in hematopoietic progenitor cells to allow broader use of chemotherapy in cancer patients without the side effect of toxicity to the hematopoietic system [11, 12] (Fig. 1). Here, ABCB1 is linked to cancer.